Sinopep-Allsino Biopharmaceutical Co. Ltd. A Asset Resilience Ratio

Latest as of June 2026: 0.91%

Sinopep-Allsino Biopharmaceutical Co. Ltd. A asset resilience ratio. Sinopep-Allsino Biopharmaceutical Co. Ltd. A (688076) has an Asset Resilience Ratio of 0.91% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Sinopep-Allsino Biopharmaceutical Co. Lt (688076) liquidity interval to measure how many days the company can operate on defensive assets alone.

Liquid Assets

CN¥64.00 Million

≈ $9.37 Million USD Cash + Short-term Investments

Total Assets

CN¥7.07 Billion

≈ $1.03 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of Sinopep-Allsino Biopharmaceutical Co. Ltd. A (2020–2025)

Asset resilience ratio of Sinopep-Allsino Biopharmaceutical Co. Ltd. A from 2020 to 2025. This chart shows how Sinopep-Allsino Biopharmaceutical Co. Ltd. A's Asset Resilience Ratio has changed over time. Read Sinopep-Allsino Biopharmaceutical Co. Lt total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Sinopep-Allsino Biopharmaceutical Co. Ltd. A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see 688076 current and non-current assets.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥64.00 Million	0.91%
Total Liquid Assets	CN¥64.00 Million	0.91%

Asset Resilience Insights

Limited Liquidity: Sinopep-Allsino Biopharmaceutical Co. Ltd. A maintains only 0.91% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Sinopep-Allsino Biopharmaceutical Co. Ltd. A Industry Peers by Asset Resilience Ratio

Compare Sinopep-Allsino Biopharmaceutical Co. Ltd. A's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
argenx NV ADR NASDAQ:ARGX	Biotechnology	15.95%
Tubize-Fin BR:TUB	Biotechnology	2.50%
Ascendis Pharma AS NASDAQ:ASND	Biotechnology	0.00%
Summit Therapeutics PLC NASDAQ:SMMT	Biotechnology	36.07%
Madrigal Pharmaceuticals Inc NASDAQ:MDGL	Biotechnology	62.31%
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	0.00%
Verona Pharma PLC ADR NASDAQ:VRNA	Biotechnology	0.00%
3SBio Inc F:83B	Biotechnology	10.64%

Sinopep-Allsino Biopharmaceutical Co. Ltd. A Asset Resilience Ratio by Year (2020–2025)

Sinopep-Allsino Biopharmaceutical Co. Ltd. A asset resilience ratio by year from 2020 to 2025. The table below shows the annual Asset Resilience Ratio data for Sinopep-Allsino Biopharmaceutical Co. Ltd. A.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	1.72%	CN¥116.00 Million ≈ $16.97 Million	CN¥6.74 Billion ≈ $986.32 Million	-2.38pp
2024-12-31	4.10%	CN¥208.00 Million ≈ $30.44 Million	CN¥5.08 Billion ≈ $743.07 Million	+2.39pp
2022-12-31	1.71%	CN¥43.01 Million ≈ $6.29 Million	CN¥2.52 Billion ≈ $369.09 Million	-2.39pp
2021-12-31	4.10%	CN¥87.13 Million ≈ $12.75 Million	CN¥2.13 Billion ≈ $311.23 Million	-1.64pp
2020-12-31	5.73%	CN¥80.00 Million ≈ $11.71 Million	CN¥1.40 Billion ≈ $204.22 Million	--

pp = percentage points

About Sinopep-Allsino Biopharmaceutical Co. Ltd. A

SHG:688076 China Biotechnology

Market Cap

$1.28 Billion

CN¥8.73 Billion CNY

Market Cap Rank

#7616 Global

#1649 in China

Share Price

CN¥27.54

Change (1 day)

+0.11%

52-Week Range

CN¥26.21 - CN¥40.22

All Time High

CN¥90.43